Ímídasókínólínafleiður sem adenósín A3 viðtakabindlar

Ímídasókínólínafleiður sem adenósín A3 viðtakabindlar

This invention is directed to a compound of formula (I), wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, Z, m, n, o, p and r are as defined herein, its preparation, pharmaceutical composition and use as an adenosine A3 receptor ligand preferably an antagonist.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KINGA BOER, PETER AR BETANYI, KATALIN URB BETAN-SZABO, GEZA TIM BETARI, ENDRE MIKUS, ZOLT BETAN KAPUI, ERZSEBET WALCZ, M BETARIA BALOGH, KATALIN GERBER, JUDIT VARG BETANE SZEREDI, L BETASZLO BAL BETAZS, S BETANDOR B BETATORI, LAJOS T. NAGY
Format: Patent
Sprache:ice
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This invention is directed to a compound of formula (I), wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, Z, m, n, o, p and r are as defined herein, its preparation, pharmaceutical composition and use as an adenosine A3 receptor ligand preferably an antagonist.